Sanofi (SNY) Liabilities and Shareholders Equity (2016 - 2026)
Sanofi's Liabilities and Shareholders Equity history spans 18 years, with the latest figure at $149.9 billion for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 8.04% to $149.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $590.7 billion, a 40.51% increase, with the full-year FY2025 number at $147.6 billion, up 4.02% from a year prior.
- Liabilities and Shareholders Equity hit $149.9 billion in Q1 2026 for Sanofi, up from $147.6 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for SNY hit a ceiling of $151.7 billion in Q3 2025 and a floor of $7.0 billion in Q4 2022.
- Historically, Liabilities and Shareholders Equity has averaged $129.2 billion across 5 years, with a median of $139.7 billion in 2024.
- Biggest five-year swings in Liabilities and Shareholders Equity: fell 3.9% in 2022 and later skyrocketed 1832.58% in 2023.
- Tracing SNY's Liabilities and Shareholders Equity over 5 years: stood at $7.0 billion in 2022, then skyrocketed by 1832.58% to $136.1 billion in 2023, then grew by 4.29% to $141.9 billion in 2024, then increased by 4.02% to $147.6 billion in 2025, then rose by 1.54% to $149.9 billion in 2026.
- Business Quant data shows Liabilities and Shareholders Equity for SNY at $149.9 billion in Q1 2026, $147.6 billion in Q4 2025, and $151.7 billion in Q3 2025.